Same Indication

Irbesartan vs Nivolumab

Irbesartan vs Nivolumab: Overview

This comparison examines the pharmacological differences between Irbesartan and Nivolumab.

Mechanism of Action

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Irbesartan — 11-15 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Irbesartan — C25H28N6O.

Molecular Weight: Irbesartan — 428.5320 g/mol.

Type: Irbesartan — Small molecule; Nivolumab — Antibody.